Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9933057rdf:typepubmed:Citationlld:pubmed
pubmed-article:9933057lifeskim:mentionsumls-concept:C0376358lld:lifeskim
pubmed-article:9933057lifeskim:mentionsumls-concept:C0441800lld:lifeskim
pubmed-article:9933057lifeskim:mentionsumls-concept:C0683312lld:lifeskim
pubmed-article:9933057lifeskim:mentionsumls-concept:C1710548lld:lifeskim
pubmed-article:9933057lifeskim:mentionsumls-concept:C1555713lld:lifeskim
pubmed-article:9933057lifeskim:mentionsumls-concept:C0332332lld:lifeskim
pubmed-article:9933057pubmed:issue2lld:pubmed
pubmed-article:9933057pubmed:dateCreated1999-3-4lld:pubmed
pubmed-article:9933057pubmed:abstractTextTo evaluate pathologic characteristics and biochemical survival rate differences between patients with Gleason score 6 or less, 7, and 8 or more prostate cancer.lld:pubmed
pubmed-article:9933057pubmed:languageenglld:pubmed
pubmed-article:9933057pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9933057pubmed:citationSubsetIMlld:pubmed
pubmed-article:9933057pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9933057pubmed:statusMEDLINElld:pubmed
pubmed-article:9933057pubmed:monthFeblld:pubmed
pubmed-article:9933057pubmed:issn0090-4295lld:pubmed
pubmed-article:9933057pubmed:authorpubmed-author:SaksTTlld:pubmed
pubmed-article:9933057pubmed:authorpubmed-author:BanerjeeMMlld:pubmed
pubmed-article:9933057pubmed:authorpubmed-author:PontesJ EJElld:pubmed
pubmed-article:9933057pubmed:authorpubmed-author:GrignonD JDJlld:pubmed
pubmed-article:9933057pubmed:authorpubmed-author:WoodD PDPJrlld:pubmed
pubmed-article:9933057pubmed:authorpubmed-author:TiguertRRlld:pubmed
pubmed-article:9933057pubmed:authorpubmed-author:GheilerE LELlld:pubmed
pubmed-article:9933057pubmed:authorpubmed-author:TefilliM VMVlld:pubmed
pubmed-article:9933057pubmed:issnTypePrintlld:pubmed
pubmed-article:9933057pubmed:volume53lld:pubmed
pubmed-article:9933057pubmed:ownerNLMlld:pubmed
pubmed-article:9933057pubmed:authorsCompleteYlld:pubmed
pubmed-article:9933057pubmed:pagination372-7lld:pubmed
pubmed-article:9933057pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:9933057pubmed:meshHeadingpubmed-meshheading:9933057-...lld:pubmed
pubmed-article:9933057pubmed:meshHeadingpubmed-meshheading:9933057-...lld:pubmed
pubmed-article:9933057pubmed:meshHeadingpubmed-meshheading:9933057-...lld:pubmed
pubmed-article:9933057pubmed:meshHeadingpubmed-meshheading:9933057-...lld:pubmed
pubmed-article:9933057pubmed:meshHeadingpubmed-meshheading:9933057-...lld:pubmed
pubmed-article:9933057pubmed:meshHeadingpubmed-meshheading:9933057-...lld:pubmed
pubmed-article:9933057pubmed:meshHeadingpubmed-meshheading:9933057-...lld:pubmed
pubmed-article:9933057pubmed:meshHeadingpubmed-meshheading:9933057-...lld:pubmed
pubmed-article:9933057pubmed:meshHeadingpubmed-meshheading:9933057-...lld:pubmed
pubmed-article:9933057pubmed:year1999lld:pubmed
pubmed-article:9933057pubmed:articleTitleShould Gleason score 7 prostate cancer be considered a unique grade category?lld:pubmed
pubmed-article:9933057pubmed:affiliationDepartment of Urology, Wayne State University School of Medicine and Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, USA.lld:pubmed
pubmed-article:9933057pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9933057lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9933057lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9933057lld:pubmed